Published in Biotech Business Week, December 25th, 2006
Unlike traditional in vitro diagnostics, whose role is largely confined to diagnosis and monitoring of a restricted range of diseases, molecular diagnostics are establishing themselves as effective tools for all aspects of disease management, especially in areas of unmet clinical need. Based on sensitive detection of disease - and often individual-specific biomarkers - such tools provide an opportunity to intercept the disease process early, stratify patients for treatment and/or predict treatment success.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.